CAR-T therapy is a groundbreaking treatment that modifies a patient’s T cells to better recognize and attack cancer cells. It’s like giving your immune system a superhero upgrade!
CAR-T therapy is currently approved for certain blood cancers, such as B-cell acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Research is ongoing for its use in solid tumors.
Yes. While CAR-T therapy was originally developed for cancer, researchers are now exploring its potential in treating autoimmune diseases by targeting specific immune cells involved in the disease process.
Harnessing the power of CAR-T cells to combat cancer with cutting-edge research and technology.
Pioneering projects that push the boundaries of immunotherapy and improve patient outcomes.
A dedicated group of experts committed to advancing cancer treatment through collaboration and innovation.
Making a difference in the lives of patients through groundbreaking research and clinical trials.
Shaping the future of cancer therapy with relentless pursuit of knowledge and excellence.
Our team has achieved a significant milestone in CAR-T cell therapy, showing promising results in early trials. Stay tuned for more updates as we continue to push the envelope in cancer research!
Our lab is staffed with top-notch researchers and clinicians who are passionate about making a difference in cancer treatment. We thrive on collaboration and innovation to achieve remarkable results.
Utilizing the latest advancements in CAR-T cell therapy, we are at the forefront of cancer research, ensuring our methods are effective and safe for patients.
Our research is driven by the needs of patients. We prioritize their well-being and aim to provide therapies that truly make a difference in their lives.
We believe in sharing our knowledge and findings with the community. Our outreach programs aim to educate and inspire the next generation of scientists and healthcare professionals.
Interested in joining our mission? We are always on the lookout for passionate individuals who want to make an impact in cancer research. Check out our recruitment page for current opportunities and become a part of our innovative team!
Projects
15
Publications
30
Awards
5
Collaborations
10
Trials
8
Welcome to the ImmunoTherapy Lab at Hallym University, where groundbreaking CAR-T cell therapy research is transforming the future of cancer treatment.
Initiated CAR-T cell therapy research, laying the foundation for innovative cancer treatments.
First successful trials conducted, showcasing the potential of CAR-T cells in targeting tumors.
Expanded research team, bringing in experts from various fields to enhance our projects.
Published groundbreaking findings in top-tier journals, gaining international recognition.
Collaborated with leading hospitals for clinical trials, pushing boundaries of cancer therapy.
Continued advancements in CAR-T technology, setting new standards in immunotherapy.
Leading research in CAR-T cell therapy.
+82-33-123-4567
immunotherapy@hallym.ac.kr
Hallym University, Chuncheon, South Korea